Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
ConditionFluid Output
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorDuke University
About this trial
The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets.
In this study, participants' hospital rooms will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.
Eligibility criteria
Qualifiers
Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic OR currently undergoing treatment for HF in the Duke Cardiology Clinic with order of strict I/O monitoring
Age 18-80 years
Karnofsky Performance Scale (KPS) ≥ 70 if a BMT patient
Able to read/write English
Disqualifiers
Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter.
Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning OR during HF treatment.
Women who are pregnant
Patient height < 5'3" if they are a patient within the Duke Cardiology Clinic
Trial design
Treatments tested in this trial
- Electronic Device for Toilet
Treatment groups
54 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov